
James William Rogers
Examiner (ID: 13796)
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618 |
| Total Applications | 1194 |
| Issued Applications | 502 |
| Pending Applications | 144 |
| Abandoned Applications | 586 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17748307
[patent_doc_number] => 20220226510
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => STIMULI-RESPONSIVE NANOPARTICLES FOR BIOMEDICAL APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 17/585118
[patent_app_country] => US
[patent_app_date] => 2022-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54156
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17585118
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/585118 | STIMULI-RESPONSIVE NANOPARTICLES FOR BIOMEDICAL APPLICATIONS | Jan 25, 2022 | Pending |
Array
(
[id] => 17836499
[patent_doc_number] => 20220273804
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => FULLERENE GABA DOPA AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/581465
[patent_app_country] => US
[patent_app_date] => 2022-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11162
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17581465
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/581465 | FULLERENE GABA DOPA AND METHODS | Jan 20, 2022 | Abandoned |
Array
(
[id] => 17836509
[patent_doc_number] => 20220273814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => C60 GLUTATHIONE DOPA AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/579967
[patent_app_country] => US
[patent_app_date] => 2022-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9957
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17579967
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/579967 | C60 GLUTATHIONE DOPA AND METHODS | Jan 19, 2022 | Abandoned |
Array
(
[id] => 17704649
[patent_doc_number] => 20220204655
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => POLYSACCHARIDES HAVING IMPROVED RADIOCONTRAST PROPERTIES
[patent_app_type] => utility
[patent_app_number] => 17/556408
[patent_app_country] => US
[patent_app_date] => 2021-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3993
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17556408
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/556408 | POLYSACCHARIDES HAVING IMPROVED RADIOCONTRAST PROPERTIES | Dec 19, 2021 | Pending |
Array
(
[id] => 19883072
[patent_doc_number] => 12268756
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-08
[patent_title] => Biocompatible magnetic materials
[patent_app_type] => utility
[patent_app_number] => 17/535168
[patent_app_country] => US
[patent_app_date] => 2021-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4819
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17535168
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/535168 | Biocompatible magnetic materials | Nov 23, 2021 | Issued |
Array
(
[id] => 17546816
[patent_doc_number] => 20220118157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => METHOD FOR BONE HEALING OR TREATMENT OF BONE FRACTURE
[patent_app_type] => utility
[patent_app_number] => 17/453129
[patent_app_country] => US
[patent_app_date] => 2021-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19148
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17453129
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/453129 | METHOD FOR BONE HEALING OR TREATMENT OF BONE FRACTURE | Oct 31, 2021 | Pending |
Array
(
[id] => 17775088
[patent_doc_number] => 20220241437
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => ATHEROSCLEROSIS IMAGING AGENTS AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/501608
[patent_app_country] => US
[patent_app_date] => 2021-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7531
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17501608
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/501608 | ATHEROSCLEROSIS IMAGING AGENTS AND METHODS OF USING THE SAME | Oct 13, 2021 | Abandoned |
Array
(
[id] => 18197209
[patent_doc_number] => 20230050728
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => METHOD OF MANUFACTURING SILICA MICROSPHERES
[patent_app_type] => utility
[patent_app_number] => 17/758560
[patent_app_country] => US
[patent_app_date] => 2021-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7216
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17758560
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/758560 | METHOD OF MANUFACTURING SILICA MICROSPHERES | Oct 4, 2021 | Pending |
Array
(
[id] => 17480722
[patent_doc_number] => 20220088226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => PYRIMIDINE NUCLEOSIDE COMPOUNDS FOR FLUORESCENCE IMAGING AND SPECTROSCOPY
[patent_app_type] => utility
[patent_app_number] => 17/476852
[patent_app_country] => US
[patent_app_date] => 2021-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10628
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17476852
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/476852 | Pyrimidine nucleoside compounds for fluorescence imaging and spectroscopy | Sep 15, 2021 | Issued |
Array
(
[id] => 19367410
[patent_doc_number] => 12059471
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-13
[patent_title] => Complex
[patent_app_type] => utility
[patent_app_number] => 17/470643
[patent_app_country] => US
[patent_app_date] => 2021-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 12
[patent_no_of_words] => 7812
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17470643
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/470643 | Complex | Sep 8, 2021 | Issued |
Array
(
[id] => 17355471
[patent_doc_number] => 20220016267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => NANOPARTICLES FOR CANCER DETECTION
[patent_app_type] => utility
[patent_app_number] => 17/408972
[patent_app_country] => US
[patent_app_date] => 2021-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35759
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17408972
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/408972 | NANOPARTICLES FOR CANCER DETECTION | Aug 22, 2021 | Abandoned |
Array
(
[id] => 17243418
[patent_doc_number] => 20210363161
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => NITROGEN-CONTAINING MACROCYCLIC CONJUGATES AS RADIOPHARMACEUTICALS
[patent_app_type] => utility
[patent_app_number] => 17/393837
[patent_app_country] => US
[patent_app_date] => 2021-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17238
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -65
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17393837
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/393837 | Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals | Aug 3, 2021 | Issued |
Array
(
[id] => 17355474
[patent_doc_number] => 20220016270
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => RADIOPAQUE MONOMERS, POLYMERS, MICROSPHERES, AND METHODS RELATED THERETO
[patent_app_type] => utility
[patent_app_number] => 17/385735
[patent_app_country] => US
[patent_app_date] => 2021-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7203
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17385735
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/385735 | Radiopaque monomers, polymers, microspheres, and methods related thereto | Jul 25, 2021 | Issued |
Array
(
[id] => 17334680
[patent_doc_number] => 20220001011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => PHOTODYNAMIC THERAPY COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/368574
[patent_app_country] => US
[patent_app_date] => 2021-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18640
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17368574
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/368574 | PHOTODYNAMIC THERAPY COMPOSITION | Jul 5, 2021 | Pending |
Array
(
[id] => 17313002
[patent_doc_number] => 20210402050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => COMPOSITE MEDICAL TEXTILE WITH NON-RESORBABLE FIBERS AND BIORESORBABLE HYALURONAN-BASED FIBERS
[patent_app_type] => utility
[patent_app_number] => 17/357345
[patent_app_country] => US
[patent_app_date] => 2021-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6882
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17357345
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/357345 | COMPOSITE MEDICAL TEXTILE WITH NON-RESORBABLE FIBERS AND BIORESORBABLE HYALURONAN-BASED FIBERS | Jun 23, 2021 | Abandoned |
Array
(
[id] => 19638117
[patent_doc_number] => 12168718
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-17
[patent_title] => Thermogelling supramolecular sponge as self-healing and biocompatible hydrogel
[patent_app_type] => utility
[patent_app_number] => 17/348157
[patent_app_country] => US
[patent_app_date] => 2021-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 35
[patent_no_of_words] => 9640
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17348157
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/348157 | Thermogelling supramolecular sponge as self-healing and biocompatible hydrogel | Jun 14, 2021 | Issued |
Array
(
[id] => 17109899
[patent_doc_number] => 20210290496
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => TOPICAL GLYCOPYRROLATE FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/339843
[patent_app_country] => US
[patent_app_date] => 2021-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14789
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17339843
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/339843 | TOPICAL GLYCOPYRROLATE FORMULATIONS | Jun 3, 2021 | Abandoned |
Array
(
[id] => 19104682
[patent_doc_number] => 11957755
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-16
[patent_title] => Radiopaque polymers
[patent_app_type] => utility
[patent_app_number] => 17/329891
[patent_app_country] => US
[patent_app_date] => 2021-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 11
[patent_no_of_words] => 12604
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17329891
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/329891 | Radiopaque polymers | May 24, 2021 | Issued |
Array
(
[id] => 17313027
[patent_doc_number] => 20210402075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => Hemocompatibility Modifiers For Cross-Linked Polymeric Material
[patent_app_type] => utility
[patent_app_number] => 17/313424
[patent_app_country] => US
[patent_app_date] => 2021-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3833
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 217
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17313424
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/313424 | Hemocompatibility Modifiers For Cross-Linked Polymeric Material | May 5, 2021 | Abandoned |
Array
(
[id] => 18496230
[patent_doc_number] => 20230218797
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => HEMOSTATIC POLYMER MATERIAL KIT
[patent_app_type] => utility
[patent_app_number] => 17/922830
[patent_app_country] => US
[patent_app_date] => 2021-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7916
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17922830
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/922830 | HEMOSTATIC POLYMER MATERIAL KIT | May 5, 2021 | Pending |